Lucid Diagnostics Inc
NASDAQ:LUCD
Lucid Diagnostics Inc
Interest Income Expense
Lucid Diagnostics Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
Interest Income Expense
$8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$375m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Lucid Diagnostics Inc's Interest Income Expense?
Interest Income Expense
8k
USD
Based on the financial report for Dec 31, 2023, Lucid Diagnostics Inc's Interest Income Expense amounts to 8k USD.